Showing 721 - 740 results of 1,139 for search '"Neuro-oncology"', query time: 0.10s Refine Results
  1. 721

    The LUMIERE dataset: Longitudinal Glioblastoma MRI with expert RANO evaluation by Yannick Suter, Urspeter Knecht, Waldo Valenzuela, Michelle Notter, Ekkehard Hewer, Philippe Schucht, Roland Wiest, Mauricio Reyes

    Published 2022-12-01
    “…We release a single-center longitudinal GBM MRI dataset with expert ratings of selected follow-up studies according to the response assessment in neuro-oncology criteria (RANO). The expert rating includes details about the rationale of the ratings. …”
    Get full text
    Article
  2. 722

    Medical and Nonmedical Information during Multidisciplinary Team Meetings in Cancer Care by Jessica Wihl, Linn Rosell, Tobias Carlsson, Sara Kinhult, Gert Lindell, Mef Nilbert

    Published 2021-02-01
    “…Data were collected from 336 case discussions in three MDTs for neuro-oncology, sarcoma and hepato-biliary cancer. Results: Information on physical status was presented in 48.2% of the case discussions, psychological status in 8.9% and comorbidity in 48.5% of the cases. …”
    Get full text
    Article
  3. 723
  4. 724
  5. 725
  6. 726

    Assessment of the clinical effectiveness and safety of immune checkpoint inhibitors for glioblastoma: A systematic review by Nicholas Calvin, Fridoline Sharon Octo

    Published 2023-12-01
    “…A total of 10 suitable articles, which encompass 168 patients (164 recurrent and 4 newly-diagnosed GBM), are taken into account. 3 studies assessed the OS, 7 studies assessed the PFS and/or response assessment in neuro-oncology (RANO) criteria and 8 studies assessed the safety, tolerability and/or adverse events. …”
    Get full text
    Article
  7. 727

    Oculomotor nerve palsy in neurofibromatosis type 2 by Aymen Shahab, MBBS, Hafsa Sardar, MBBS, Samaa Akhtar, MD, MSc, Anam Safdar, MBBS,FCPS, Muhammad Ismail Safi, MD, Izaz Ahmad, Faheemullah Khan, MBBS,MD

    Published 2022-11-01
    “…The patient was referred for specific treatment to the neuro-oncology unit. The case is distinct as the patient presented with a parasellar meningioma leading to third nerve palsy besides bilateral vestibular schwannomas. …”
    Get full text
    Article
  8. 728

    Molecular Targeted Therapies: Time for a Paradigm Shift in Medulloblastoma Treatment? by Lidia Gatto, Enrico Franceschi, Alicia Tosoni, Vincenzo Di Nunno, Stefania Bartolini, Alba Ariela Brandes

    Published 2022-01-01
    “…Adult medulloblastoma, in particular, is considered a rarer “orphan” entity in neuro-oncology practice because while treatments have progressively evolved for the pediatric population, no practice-changing prospective, randomized clinical trials have been performed in adults. …”
    Get full text
    Article
  9. 729
  10. 730
  11. 731

    RETRACTED: The efficacy and adverse effects of anlotinib in the treatment of high-grade glioma: A retrospective analysis by Fangcheng Shen, Jing Li, Feng Liu, Ni Sun, XiangNan Qiu, Wei Ding, XiangDong Sun

    Published 2023-02-01
    “…Efficacy was evaluated according to the Response Assessment in Neuro-Oncology (RANO) criteria, and the main study endpoints were PFS at 6 months and overall survival (OS) at 1 year.ResultsAfter the follow-up, until May 2022, 13 patients survived and 13 patients died, with a median follow-up time of 25.6 months. …”
    Get full text
    Article
  12. 732
  13. 733
  14. 734
  15. 735
  16. 736
  17. 737
  18. 738

    Checkpoint Inhibitors as High-Grade Gliomas Treatment: State of the Art and Future Perspectives by Pasquale Persico, Elena Lorenzi, Angelo Dipasquale, Federico Pessina, Pierina Navarria, Letterio S. Politi, Armando Santoro, Matteo Simonelli

    Published 2021-03-01
    “…Unfortunately, these clinical successes have not been replicated in the neuro-oncology field so far. This review summarizes the status of ICI investigation in high-grade gliomas, critically presenting the available data from preclinical models and clinical trials. …”
    Get full text
    Article
  19. 739
  20. 740